| Range: | 3.0-8.85 | Vol Avg: | 13 | Last Div: | 0 | Changes: | 0.25 |
| Beta: | 0 | Cap: | 0.07B | Currency: | USD | Exchange: | PNK |
| Sector: | Financial Services | IPO: | Thu Jan 02 1997 | Empoloyees: | |||
| CUSIP: | CIK: | ISIN: | US70557B2043 | Country: | US | ||
| CEO: | Mr. Daniel P. Kesonen | Website: | https://www.pegasusbiosciences.com | ||||
DVTC 10.00 Stock Price Development Technologies Corp.
Pegasus Pharmaceuticals Inc. manufactures and provides an advanced ECG system for the non-invasive screening of heart pathologies. The company offers HeartVue 6S System, which is a screening tool used to diagnose heart and other cardiac diseases. It serves cardiologists, general practitioners, physicians, intensive care units, hospitals, emergency rooms, clinics, fitness facilities, sports teams, and other emergency medical facilities. Pegasus Pharmaceuticals Inc. was founded in 1995 and is headquartered in Palm Beach Gardens, Florida.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow